Studying a blood signal in active spondyloarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years old).
- You have been diagnosed with spondyloarthritis using ASAS criteria.
- Your disease is currently active (for example, painful inflammation in joints, tendon areas, or spine).
- You can sign informed consent and agree to study procedures.
- You do not have the study’s pregnancy/breastfeeding, refusal, or special legal/protection exclusions.
- You are not using certain immune-suppressing situations (like prior multiple biologics or high-dose steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the gut microbiome (the bacteria in your intestines) in adults with spondyloarthritis or rheumatoid arthritis versus healthy adults. It aims to better describe differences that may help explain these diseases.
This study looks at the cells and molecules in the joint tissue of people with arthritis. The goal is to better understand arthritis and potentially improve treatments.
This study looks at your gut bacteria (from a stool sample) to see whether it can predict how well you will respond to biologic medicines for spondyloarthritis. It may help doctors choose the most effective treatment for future patients.
This study follows people recently diagnosed with spondyloarthritis (a type of inflammatory arthritis) to understand how the disease changes over time. It aims to improve early detection and treatment.
This study collects and stores health information and samples for people with long-term inflammatory arthritis (like rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis) or with osteoporosis. It helps researchers understand these conditions and may lead to better future treatments.
This study looks at stool (poop) samples to see whether gut bacteria patterns can help identify certain inflammatory arthritis conditions in people who have Crohn’s disease or axial spondyloarthritis. It’s mainly about matching stool “biomarkers” to diagnoses, which may help doctors recognize these conditions more accurately in the future.
Hear when a new Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.